News

Research published at the start of 2022 suggested that the Epstein-Barr virus (EBV) is a causal factor in the development of the neurodegenerative condition multiple sclerosis (MS).

Scientists in Switzerland have developed a peptide that binds to the protein calprotectin, a marker of major inflammatory disorders, and shown that it is suitable for diagnostic tests.

Common food allergens were detected using a NIR spectroscopy method in a new study, which the researchers say is fast, easy, non-invasive, inexpensive and accurate.

To increase the shelf life of strawberries, researchers have incorporated cannabidiol — a non-hallucinogenic compound from cannabis known as CBD — and sodium alginate into an edible antimicrobial coating.

Researchers have conducted a first-of-its-kind study that shows an association between gut microbiota and postoperative delirium.

A study has suggested that a new, less toxic form of an old and neglected antibiotic, nourseothricin, may protect against multidrug-resistant infections.

Researchers develop objective criteria, which can be automated, to classify B and T cell clonality results as positive (clonal), no evidence of clonality or invalid (failed).

A new antibiotic combination has been shown to be effective against hospital-acquired pneumonia in a phase three clinical trial.

Non-nutritive sweeteners, commonly used in diet drinks, have been shown to impact gene expression in white blood cells, which researchers suggest may sensitize the immune cells to certain stimuli.

A team of researchers has discovered how a deadly hospital pathogen can survive harsh environments and then rebound, causing deadly infections.